Covis Pharma
  • About
    • Team
    • Partnerships
  • Products
    • Alvesco
    • Feraheme
    • Makena
    • All products
  • Co-Pay
  • News
  • Careers
  • Contact
Select Page

News release 2013

Covis Pharma to Acquire US Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®

April 4, 2013

News release

  • 2022
  • 2021
  • 2020
  • 2018
  • 2017
  • 2015
  • 2013
Skip to content
Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset